Adma Biologics, Inc. financial data

Symbol
ADMA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
C/O Adma Biologics, Inc., 465 State Route 17, Ramsey, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
R&R ACQUISITION VI, INC (to 2/21/2012)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 575 % -13%
Quick Ratio 362 % -15.5%
Debt-to-equity 134 % -11.5%
Return On Equity -2.48 % +93.3%
Return On Assets -1.06 % +92.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 232M shares +4.35%
Common Stock, Shares, Outstanding 232M shares +4.28%
Entity Public Float 794M USD +113%
Common Stock, Value, Issued 23K USD +3.48%
Weighted Average Number of Shares Outstanding, Basic 229M shares +3.13%
Weighted Average Number of Shares Outstanding, Diluted 236M shares +6.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 283M USD +55.7%
Cost of Revenue 172M USD +28.3%
Research and Development Expense 2.9M USD -24.7%
Operating Income (Loss) 44.3M USD
Nonoperating Income (Expense) -47.3M USD -112%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 18.4M USD
Income Tax Expense (Benefit) 595K USD
Net Income (Loss) Attributable to Parent -3.64M USD +92.4%
Earnings Per Share, Basic -0.02 USD/shares +91.3%
Earnings Per Share, Diluted -0.02 USD/shares +91.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 45.3M USD -34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 49.6M USD +87.1%
Inventory, Net 178M USD +8.38%
Assets, Current 276M USD +4.67%
Property, Plant and Equipment, Net 55.3M USD -3.58%
Operating Lease, Right-of-Use Asset 9.4M USD -8.3%
Intangible Assets, Net (Excluding Goodwill) 321K USD -61.5%
Goodwill 3.53M USD +0.01%
Assets 351M USD +2.96%
Accounts Payable, Current 17.2M USD +32.6%
Contract with Customer, Liability, Current 1.12M USD +683%
Liabilities, Current 53.1M USD +44.5%
Operating Lease, Liability, Noncurrent 9.49M USD -9.37%
Other Liabilities, Noncurrent 405K USD +19.6%
Liabilities 197M USD +1.04%
Retained Earnings (Accumulated Deficit) -488M USD -0.75%
Stockholders' Equity Attributable to Parent 154M USD +5.53%
Liabilities and Equity 351M USD +2.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.22M USD +84.9%
Net Cash Provided by (Used in) Financing Activities -1.45M USD -123%
Net Cash Provided by (Used in) Investing Activities -2.36M USD -21.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 232M shares +4.28%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.03M USD +65.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 45.3M USD -34.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 584K USD -87.4%
Deferred Tax Assets, Valuation Allowance 101M USD +4.86%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 101M USD +4.86%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +20.7%
Lessee, Operating Lease, Liability, to be Paid 16.7M USD -11.9%
Property, Plant and Equipment, Gross 84M USD +6.75%
Operating Lease, Liability, Current 1.09M USD +14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.16M USD -8.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.42M USD +3.32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.08M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.04M USD -3.55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09M USD +2.32%
Operating Lease, Payments 2.4M USD +20%
Additional Paid in Capital 642M USD +1.86%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 738K USD +3.19%
Depreciation, Depletion and Amortization 7.6M USD +10.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 22.7M USD +3.07%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%